Logo image of TEAM

ATLASSIAN CORP-CL A (TEAM) Stock Fundamental Analysis

USA - NASDAQ:TEAM - US0494681010 - Common Stock

169.492 USD
+0.78 (+0.46%)
Last: 10/22/2025, 3:42:06 PM
Fundamental Rating

4

TEAM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. TEAM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TEAM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TEAM had positive earnings in the past year.
TEAM had a positive operating cash flow in the past year.
In the past 5 years TEAM always reported negative net income.
In the past 5 years TEAM always reported a positive cash flow from operatings.
TEAM Yearly Net Income VS EBIT VS OCF VS FCFTEAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -4.25%, TEAM is in line with its industry, outperforming 45.61% of the companies in the same industry.
TEAM has a Return On Equity of -19.08%. This is comparable to the rest of the industry: TEAM outperforms 42.46% of its industry peers.
Industry RankSector Rank
ROA -4.25%
ROE -19.08%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TEAM Yearly ROA, ROE, ROICTEAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 82.84%, TEAM belongs to the top of the industry, outperforming 89.82% of the companies in the same industry.
In the last couple of years the Gross Margin of TEAM has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for TEAM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.12%
TEAM Yearly Profit, Operating, Gross MarginsTEAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

5

2. Health

2.1 Basic Checks

TEAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for TEAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TEAM Yearly Shares OutstandingTEAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TEAM Yearly Total Debt VS Total AssetsTEAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

TEAM has an Altman-Z score of 5.60. This indicates that TEAM is financially healthy and has little risk of bankruptcy at the moment.
TEAM's Altman-Z score of 5.60 is fine compared to the rest of the industry. TEAM outperforms 70.88% of its industry peers.
TEAM has a debt to FCF ratio of 0.70. This is a very positive value and a sign of high solvency as it would only need 0.70 years to pay back of all of its debts.
The Debt to FCF ratio of TEAM (0.70) is better than 77.19% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that TEAM is somewhat dependend on debt financing.
TEAM has a worse Debt to Equity ratio (0.73) than 70.88% of its industry peers.
Although TEAM does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 0.7
Altman-Z 5.6
ROIC/WACCN/A
WACC11.35%
TEAM Yearly LT Debt VS Equity VS FCFTEAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

TEAM has a Current Ratio of 1.22. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TEAM (1.22) is worse than 61.40% of its industry peers.
TEAM has a Quick Ratio of 1.22. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TEAM (1.22) is worse than 61.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
TEAM Yearly Current Assets VS Current LiabilitesTEAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.60% over the past year.
Measured over the past years, TEAM shows a very strong growth in Earnings Per Share. The EPS has been growing by 26.19% on average per year.
Looking at the last year, TEAM shows a quite strong growth in Revenue. The Revenue has grown by 19.66% in the last year.
TEAM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.43% yearly.
EPS 1Y (TTM)25.6%
EPS 3Y29.36%
EPS 5Y26.19%
EPS Q2Q%48.48%
Revenue 1Y (TTM)19.66%
Revenue growth 3Y23%
Revenue growth 5Y26.43%
Sales Q2Q%22.34%

3.2 Future

Based on estimates for the next years, TEAM will show a very strong growth in Earnings Per Share. The EPS will grow by 21.58% on average per year.
Based on estimates for the next years, TEAM will show a quite strong growth in Revenue. The Revenue will grow by 17.68% on average per year.
EPS Next Y17.87%
EPS Next 2Y20.21%
EPS Next 3Y21.28%
EPS Next 5Y21.58%
Revenue Next Year18.95%
Revenue Next 2Y18.95%
Revenue Next 3Y19.1%
Revenue Next 5Y17.68%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TEAM Yearly Revenue VS EstimatesTEAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
TEAM Yearly EPS VS EstimatesTEAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

TEAM is valuated quite expensively with a Price/Earnings ratio of 46.06.
TEAM's Price/Earnings ratio is in line with the industry average.
TEAM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.77.
With a Price/Forward Earnings ratio of 39.08, TEAM can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TEAM is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of TEAM to the average of the S&P500 Index (23.23), we can say TEAM is valued expensively.
Industry RankSector Rank
PE 46.06
Fwd PE 39.08
TEAM Price Earnings VS Forward Price EarningsTEAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TEAM is valued a bit cheaper than the industry average as 71.58% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 31.41
EV/EBITDA N/A
TEAM Per share dataTEAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TEAM's earnings are expected to grow with 21.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.58
PEG (5Y)1.76
EPS Next 2Y20.21%
EPS Next 3Y21.28%

0

5. Dividend

5.1 Amount

TEAM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATLASSIAN CORP-CL A

NASDAQ:TEAM (10/22/2025, 3:42:06 PM)

169.492

+0.78 (+0.46%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners95.1%
Inst Owner Change0.38%
Ins Owners0.31%
Ins Owner Change17.48%
Market Cap44.46B
Revenue(TTM)5.22B
Net Income(TTM)-256687000
Analysts81.05
Price Target256.55 (51.36%)
Short Float %3.45%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.55%
Min EPS beat(2)2.87%
Max EPS beat(2)12.23%
EPS beat(4)4
Avg EPS beat(4)14.16%
Min EPS beat(4)2.87%
Max EPS beat(4)24.37%
EPS beat(8)8
Avg EPS beat(8)17.16%
EPS beat(12)11
Avg EPS beat(12)20.7%
EPS beat(16)14
Avg EPS beat(16)20.68%
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)0.1%
Revenue beat(4)3
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)1.7%
Revenue beat(8)5
Avg Revenue beat(8)0.8%
Revenue beat(12)7
Avg Revenue beat(12)0.45%
Revenue beat(16)11
Avg Revenue beat(16)1.29%
PT rev (1m)-0.73%
PT rev (3m)-9.98%
EPS NQ rev (1m)0.24%
EPS NQ rev (3m)-8.69%
EPS NY rev (1m)-0.23%
EPS NY rev (3m)0.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 46.06
Fwd PE 39.08
P/S 8.53
P/FCF 31.41
P/OCF 30.45
P/B 33.04
P/tB N/A
EV/EBITDA N/A
EPS(TTM)3.68
EY2.17%
EPS(NY)4.34
Fwd EY2.56%
FCF(TTM)5.4
FCFY3.18%
OCF(TTM)5.57
OCFY3.28%
SpS19.88
BVpS5.13
TBVpS-0.78
PEG (NY)2.58
PEG (5Y)1.76
Graham Number20.61
Profitability
Industry RankSector Rank
ROA -4.25%
ROE -19.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.84%
FCFM 27.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.12%
F-Score8
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 0.7
Debt/EBITDA N/A
Cap/Depr 48.55%
Cap/Sales 0.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 5.6
F-Score8
WACC11.35%
ROIC/WACCN/A
Cap/Depr(3y)44.32%
Cap/Depr(5y)67.34%
Cap/Sales(3y)0.78%
Cap/Sales(5y)1.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.6%
EPS 3Y29.36%
EPS 5Y26.19%
EPS Q2Q%48.48%
EPS Next Y17.87%
EPS Next 2Y20.21%
EPS Next 3Y21.28%
EPS Next 5Y21.58%
Revenue 1Y (TTM)19.66%
Revenue growth 3Y23%
Revenue growth 5Y26.43%
Sales Q2Q%22.34%
Revenue Next Year18.95%
Revenue Next 2Y18.95%
Revenue Next 3Y19.1%
Revenue Next 5Y17.68%
EBIT growth 1Y-11.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.12%
EBIT Next 3Y24.45%
EBIT Next 5Y22.29%
FCF growth 1Y0.04%
FCF growth 3Y23.78%
FCF growth 5Y21.32%
OCF growth 1Y0.84%
OCF growth 3Y21.16%
OCF growth 5Y20.53%